Of the four subtypes, the LA subtype tends to have the best prognosis, fairly high survival, and low recurrent or metastases rates. The TN and HER2 subtypes of breast cancer were associated with significantly poorer overall survival and were prone to earlier recurrence and metastases. The gene discussed is ERBB2; the disease is breast carcinoma.